Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 3
1951 4
1954 2
1955 2
1956 3
1958 1
1960 1
1962 1
1964 1
1965 3
1966 7
1967 3
1968 4
1969 4
1970 7
1971 6
1972 3
1973 5
1974 5
1975 3
1977 3
1978 1
1979 2
1980 3
1981 3
1982 3
1983 4
1984 2
1985 2
1986 3
1987 11
1988 10
1989 14
1990 16
1991 9
1992 19
1993 12
1994 28
1995 15
1996 15
1997 23
1998 54
1999 80
2000 70
2001 70
2002 98
2003 107
2004 113
2005 160
2006 176
2007 171
2008 147
2009 152
2010 151
2011 197
2012 207
2013 226
2014 311
2015 380
2016 419
2017 481
2018 633
2019 680
2020 843
2021 1045
2022 1091
2023 1220
2024 1264
2025 676

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,130 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Borromeo-Ferri
Page 1
Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis).
Wang Z, Zhang X, Luo Y, Song Y, Xiang C, He Y, Wang K, Yu Y, Wang Z, Peng W, Ding Y, Liu S, Wu C. Wang Z, et al. Cell Death Dis. 2024 May 29;15(5):375. doi: 10.1038/s41419-024-06751-1. Cell Death Dis. 2024. PMID: 38811536 Free PMC article.
In this study, we observed that ARID1A-deficient colorectal cancer (CRC) cells showed synthetic lethal effects with a p53 activator, RITA (reactivating p53 and inducing tumor apoptosis). RITA, an inhibitor of the p53-MDM2 interaction, exhibits increased sensitivity …
In this study, we observed that ARID1A-deficient colorectal cancer (CRC) cells showed synthetic lethal effects with a p53 activator, RITA …
Rita Levi-Montalcini: the neurologist who challenged fascism.
Coutinho L, Teive HAG. Coutinho L, et al. Arq Neuropsiquiatr. 2023 Jan;81(1):95-98. doi: 10.1055/s-0043-1761426. Epub 2023 Mar 14. Arq Neuropsiquiatr. 2023. PMID: 36918012 Free PMC article. Review.
Rita Levi-Montalcini was a researcher in the field of neuroscience, Italian and Jewish in origin, who discovered the nerve growth factor and rightfully earned the 1986 Nobel Prize in Physiology or Medicine, alongside her collaborator Stanley Cohen. ...This paper reviews th …
Rita Levi-Montalcini was a researcher in the field of neuroscience, Italian and Jewish in origin, who discovered the nerve growth fac …
Rita Levi and Nerve Growth Factor.
Pai-Dhungat JV. Pai-Dhungat JV. J Assoc Physicians India. 2023 Sep;71(9):106. doi: 10.59556/japi.71.0343. J Assoc Physicians India. 2023. PMID: 38700311
How to cite this article: Pai-Dhungat JV. Rita Levi and Nerve Growth Factor. J Assoc Physicians India 2023;71(9):106-106....
How to cite this article: Pai-Dhungat JV. Rita Levi and Nerve Growth Factor. J Assoc Physicians India 2023;71(9):106-106....
The radial artery: a forgotten conduit.
Gaudino M, Crea F, Cammertoni F, Massetti M. Gaudino M, et al. Ann Thorac Surg. 2015 Apr;99(4):1479-85. doi: 10.1016/j.athoracsur.2014.11.045. Epub 2015 Feb 26. Ann Thorac Surg. 2015. PMID: 25725926 Review.
The RA is a better graft than the saphenous vein and comparable to the right internal thoracic artery (RITA); moreover, the RA seems a better choice than the RITA in patients at risk of sternal or pulmonary complications. We conclude that the RA should be preferred …
The RA is a better graft than the saphenous vein and comparable to the right internal thoracic artery (RITA); moreover, the RA seems …
Why Are We Scientists? Drawing Inspiration From Rita Levi-Montalcini.
Malerba F. Malerba F. Front Cell Neurosci. 2022 Jan 21;15:741984. doi: 10.3389/fncel.2021.741984. eCollection 2021. Front Cell Neurosci. 2022. PMID: 35126056 Free PMC article. Review.
In 2007, drawing inspiration from her previous experiments on chick embryos, Rita Levi-Montalcini, at the age of 98, proposed a new project, and a research group, in which I was included, was formed at the European Brain Research Institute (EBRI). ...Indeed, I believe the …
In 2007, drawing inspiration from her previous experiments on chick embryos, Rita Levi-Montalcini, at the age of 98, proposed a new p …
Bilateral internal thoracic artery grafting: in situ or composite?
Kawajiri H, Grau JB, Fortier JH, Glineur D. Kawajiri H, et al. Ann Cardiothorac Surg. 2018 Sep;7(5):673-680. doi: 10.21037/acs.2018.05.16. Ann Cardiothorac Surg. 2018. PMID: 30505752 Free PMC article.
Composite BITA grafting is the other option that maximizes right ITA (RITA) utilization. In this configuration, the RITA is able to reach the distal circumflex and right coronary artery branches. ...
Composite BITA grafting is the other option that maximizes right ITA (RITA) utilization. In this configuration, the RITA is ab …
Radial Artery Versus Right Internal Thoracic Artery Versus Saphenous Vein as the Second Conduit for Coronary Artery Bypass Surgery: A Network Meta-Analysis of Clinical Outcomes.
Gaudino M, Lorusso R, Rahouma M, Abouarab A, Tam DY, Spadaccio C, Saint-Hilary G, Leonard J, Iannaccone M, D'Ascenzo F, Di Franco A, Soletti G, Kamel MK, Lau C, Girardi LN, Schwann TA, Benedetto U, Taggart DP, Fremes SE. Gaudino M, et al. J Am Heart Assoc. 2019 Jan 22;8(2):e010839. doi: 10.1161/JAHA.118.010839. J Am Heart Assoc. 2019. PMID: 30636525 Free PMC article.
A total of 149 902 patients (4 randomized, 31 observational studies) were included ( RA , 16 201, SV , 112 018, RITA, 21 683). At NMA , the use of SV was associated with higher long-term mortality compared with the RA (incidence rate ratio, 1.23; 95% CI , 1.12-1.34) and …
A total of 149 902 patients (4 randomized, 31 observational studies) were included ( RA , 16 201, SV , 112 018, RITA, 21 683). At NMA …
Long-Term Results of the RAPCO Trials.
Buxton BF, Hayward PA, Raman J, Moten SC, Rosalion A, Gordon I, Seevanayagam S, Matalanis G, Benedetto U, Gaudino M, Hare DL; RAPCO Investigators*. Buxton BF, et al. Circulation. 2020 Oct 6;142(14):1330-1338. doi: 10.1161/CIRCULATIONAHA.119.045427. Epub 2020 Oct 5. Circulation. 2020. PMID: 33017209 Clinical Trial.
The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). METHODS: In RAPCO-RITA (the RITA versus …
The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with …
An Interview with Rita Charon.
Carlin N. Carlin N. J Med Humanit. 2025 Jan 17. doi: 10.1007/s10912-024-09924-3. Online ahead of print. J Med Humanit. 2025. PMID: 39821887
This is an edited transcript of an interview with Rita Charon. Nathan Carlin conducted the interview in her apartment in New York City on October 18, 2024. ...
This is an edited transcript of an interview with Rita Charon. Nathan Carlin conducted the interview in her apartment in New York Cit …
10,130 results
You have reached the last available page of results. Please see the User Guide for more information.